Moneycontrol
Jan 09, 2017 10:51 AM IST IST | Source: Moneycontrol.com

Divis Lab: Update on USFDA inspection of Unit-II at Visakhapatnam

Divis Laboratories Ltd has informed BSE that the company has already filed its detailed response to the ‘Form 483’ observations of the US-FDA within the time permitted.

Divis Laboratories Ltd has informed BSE that the company has already filed its detailed response to the

Sections
Follow us on
Available On